These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6643282)

  • 1. Chemical modification of spiramycins. I. Synthesis of the acetal derivatives of neospiramycin I.
    Sano H; Inoue M; Yamashita K; Okachi R; Omura S
    J Antibiot (Tokyo); 1983 Oct; 36(10):1336-44. PubMed ID: 6643282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical modification of spiramycins. II. Synthesis and antimicrobial activity of 4'-deoxy derivatives of neospiramycin I and their 12-(Z)-isomers.
    Sano H; Inoue M; Omura S
    J Antibiot (Tokyo); 1984 Jul; 37(7):738-49. PubMed ID: 6469868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical modification of spiramycins. III. Synthesis and antibacterial activities of 4''-sulfonates and 4''-alkylethers of spiramycin I.
    Sano H; Sunazuka T; Tanaka H; Yamashita K; Okachi R; Omura S
    J Antibiot (Tokyo); 1984 Jul; 37(7):750-9. PubMed ID: 6469869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical modification of tylosin: synthesis of amino derivatives at C-20 position of tylosin and demycarosyltylosin.
    Matsubara H; Inokoshi J; Nakagawa A; Tanaka H; Omura S
    J Antibiot (Tokyo); 1983 Dec; 36(12):1713-21. PubMed ID: 6662813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical modification of spiramycins. VI. Synthesis and antibacterial activities of 3,3''-di-O-acyl-4''-O-sulfonyl and 3,3''-di-O-acyl-4''-O-alkyl derivatives of spiramycin I.
    Sano M; Sunazuka T; Tanaka H; Yamashita K; Okachi R; Omura S
    J Antibiot (Tokyo); 1985 Oct; 38(10):1350-8. PubMed ID: 4066488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syntheses of 23-C-alkylidene, and 23-N-containing derivatives of 5-O-mycaminosyltylonolide.
    Kajikawa N; Tsuchiya T; Umezawa S; Umezawa H
    J Antibiot (Tokyo); 1987 Apr; 40(4):476-82. PubMed ID: 3583916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 4'''-N-demethylspiramycin derivatives: synthesis and evaluation of effectiveness against drug-resistant bacteria.
    Sunazuka T; Shudo H; Nagai K; Yoshida K; Yamaguchi Y; Hanaki H; Omura S
    J Antibiot (Tokyo); 2008 Mar; 61(3):175-84. PubMed ID: 18503196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure activity relationships of spiramycins.
    Omura S; Sano H; Sunazuka T
    J Antimicrob Chemother; 1985 Jul; 16 Suppl A():1-11. PubMed ID: 3902764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical modification of spiramycins. IV. Synthesis and in vitro and in vivo activities of 3'',4''-diacylates and 3,3'',4''-triacylates of spriamycin I.
    Sano H; Sunazuka T; Tanaka H; Yamashita K; Okachi R; Omura S
    J Antibiot (Tokyo); 1984 Jul; 37(7):760-72. PubMed ID: 6469870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical modification of spiramycins. V. Synthesis and antibacterial activity of 3'- or 4''-de-N-methylspiramycin I and their N-substituted derivatives.
    Sano H; Tanaka H; Yamashita K; Okachi R; Omura S
    J Antibiot (Tokyo); 1985 Feb; 38(2):186-96. PubMed ID: 3997666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and in vitro antibacterial activity of catechol-spiramycin conjugates.
    Poras H; Kunesch G; Barrière JC; Berthaud N; Andremont A
    J Antibiot (Tokyo); 1998 Aug; 51(8):786-94. PubMed ID: 9766470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acyl derivatives of 16-membered macrolides. I. Synthesis and biological properties of 3"-O-propionylleucomycin A5 (TMS-19-Q).
    Sakakibara H; Okekawa O; Fujiwara T; Otani M; Omura S
    J Antibiot (Tokyo); 1981 Aug; 34(8):1001-10. PubMed ID: 7319915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of 7'-(3-hydroxypropyl)fortimicin A and 6'-epifortimicin A.
    Kanai K; Nishigaki J; Taki T; Ogawa S; Suami T
    Carbohydr Res; 1987 Dec; 170(1):47-55. PubMed ID: 3435904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1H-NMR and 13C-NMR spectral assignments of spiramycins I and III.
    Ramu K; Shringarpure S; Cooperwood S; Beale JM; Williams JS
    Pharm Res; 1994 Mar; 11(3):458-65. PubMed ID: 8008717
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemical modification of tylosin. Thioether derivatives of tylosin and demycarosyltylosin.
    Omura S; Matsubara H; Tsuzuki K; Nakagawa A
    J Antibiot (Tokyo); 1984 Sep; 37(9):1007-15. PubMed ID: 6501102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syntheses of 23-dialkylamino derivatives of mycaminosyl tylonolide and 4'-deoxymycaminosyl tylonolide effective against gram-negative bacteria.
    Tanaka A; Tsuchiya T; Okada Y; Umezawa S; Hamada M; Umezawa H
    J Antibiot (Tokyo); 1982 Jan; 35(1):113-6. PubMed ID: 7068511
    [No Abstract]   [Full Text] [Related]  

  • 17. [Spiramycin derivatives. 1].
    Takahira H
    Jpn J Antibiot; 1970 Aug; 23(4):424-8. PubMed ID: 5312794
    [No Abstract]   [Full Text] [Related]  

  • 18. Two novel spiramycins obtained from commercial samples: isolation and elucidation of structure.
    Liu L; Roets E; Busson R; Vankeerberghen A; Janssen G; Hoogmartens J
    J Antibiot (Tokyo); 1996 Apr; 49(4):398-401. PubMed ID: 8642006
    [No Abstract]   [Full Text] [Related]  

  • 19. 19-Deformyl-4'-deoxydesmycosin (TMC-016): synthesis and biological properties of a unique 16-membered macrolide antibiotic.
    Fujiwara T; Watanabe H; Kogami Y; Shiritani Y; Sakakibara H
    J Antibiot (Tokyo); 1989 Jun; 42(6):903-12. PubMed ID: 2500413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationships among the O-acyl derivatives of leucomycin. Correlation of minimal inhibitory concentrations with binding to Escherichia coli ribosomes.
    Omura S; Nakagawa A; Sakakibara H; Okekawa O; Brandsch R
    J Med Chem; 1977 May; 20(5):732-6. PubMed ID: 404425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.